Literature DB >> 19752005

Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.

Rudolf Lichtenfels1, Sven P Dressler, Monica Zobawa, Christian V Recktenwald, Angelika Ackermann, Derek Atkins, Michael Kersten, Andrea Hesse, Maria Puttkammer, Friedrich Lottspeich, Barbara Seliger.   

Abstract

Proteome-based technologies represent powerful tools for the analysis of protein expression profiles, including the identification of potential cancer candidate biomarkers. Thus, here we provide a comprehensive protein expression map for clear cell renal cell carcinoma established by systematic comparative two-dimensional gel electrophoresis-based protein expression profiling of 16 paired tissue systems comprising clear cell renal cell carcinoma lesions and corresponding tumor-adjacent renal epithelium using overlapping narrow pH gradients. This approach led to the mapping of 348 distinct spots corresponding to 248 different protein identities. By implementing restriction criteria concerning their detection frequency and overall regulation mode, 28 up- and 56 down-regulated single target spots were considered as potential candidate biomarkers. Based on their gene ontology information, these differentially expressed proteins were classified into distinct functional groups and according to their cellular distribution. Moreover, three representative members of this group, namely calbindin, gelsolin, and heart fatty acid-binding protein, were selected, and their expression pattern was analyzed by immunohistochemistry using tissue microarrays. Thus, this pilot study provides a significant update of the current renal cell carcinoma map and defines a number of differentially expressed proteins, but both their potential as candidate biomarkers and clinical relevance has to be further explored in tissues and for body fluids like serum and urine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752005      PMCID: PMC2816012          DOI: 10.1074/mcp.M900168-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  53 in total

Review 1.  The fatty acid transport function of fatty acid-binding proteins.

Authors:  J Storch; A E Thumser
Journal:  Biochim Biophys Acta       Date:  2000-06-26

2.  Use of a sensitive EnVision +-based detection system for Western blotting: avoidance of streptavidin binding to endogenous biotin and biotin-containing proteins in kidney and other tissues.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia A Harnden; Peter J Selby
Journal:  Proteomics       Date:  2003-04       Impact factor: 3.984

3.  Calbindin-D28k is expressed in osteoblastic cells and suppresses their apoptosis by inhibiting caspase-3 activity.

Authors:  T Bellido; M Huening; M Raval-Pandya; S C Manolagas; S Christakos
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

4.  Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.

Authors:  Harri Visapää; Matthew Bui; Yunda Huang; David Seligson; Henry Tsai; Allan Pantuck; Robert Figlin; Jian Y u Rao; Arie Belldegrun; Steve Horvath; Aarno Palotie
Journal:  Urology       Date:  2003-04       Impact factor: 2.649

5.  Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma.

Authors:  Rudolf Lichtenfels; Roland Kellner; Jürgen Bukur; Joachim Beck; Walburgis Brenner; Angelika Ackermann; Barbara Seliger
Journal:  Proteomics       Date:  2002-05       Impact factor: 3.984

6.  Overexpression of KIT in chromophobe renal cell carcinoma.

Authors:  Ken Yamazaki; Michiie Sakamoto; Tsutomu Ohta; Yae Kanai; Misao Ohki; Setsuo Hirohashi
Journal:  Oncogene       Date:  2003-02-13       Impact factor: 9.867

7.  Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

Authors:  John P T Higgins; Rajesh Shinghal; Harcharan Gill; Jeffrey H Reese; Martha Terris; Ronald J Cohen; Michael Fero; Jonathan R Pollack; Matt van de Rijn; James D Brooks
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

8.  Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy.

Authors:  Barbara Seliger; Matthias Menig; Rudolf Lichtenfels; Derek Atkins; Jürgen Bukur; Thomas M Halder; Michael Kersten; Alois Harder; Angelika Ackermann; Joachim Beck; Bernd Muehlenweg; Walburgis Brenner; Sebastian Melchior; Roland Kellner; Friedrich Lottspeich
Journal:  Proteomics       Date:  2003-06       Impact factor: 3.984

Review 9.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

10.  Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses.

Authors:  Rudolf Lichtenfels; Roland Kellner; Derek Atkins; Jürgen Bukur; Angelika Ackermann; Joachim Beck; Walburgis Brenner; Sebastian Melchior; Barbara Seliger
Journal:  Biochim Biophys Acta       Date:  2003-03-21
View more
  13 in total

1.  [Quantitative and comparative proteomics analysis in clear cell renal cell carcinoma and adjacent noncancerous tissues by 2-D DIGE].

Authors:  Zhuang-Fei Chen; Yao-Jun Xiao; Ze-Hai Huang; Tong Chen; Shan-Chao Zhao; Yao-Dong Jiang; Peng Wu; Shao-Bin Zheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

2.  Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?

Authors:  Barbara Seliger; Simon Jasinski; Sven P Dressler; Francesco M Marincola; Christian V Recktenwald; Ena Wang; Rudolf Lichtenfels
Journal:  J Proteome Res       Date:  2011-01-07       Impact factor: 4.466

3.  Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells.

Authors:  Barbara Seliger; Sven P Dressler; Chiara Massa; Christian V Recktenwald; Florian Altenberend; Juergen Bukur; Francesco M Marincola; Ena Wang; Stefan Stevanovic; Rudolf Lichtenfels
Journal:  Proteomics       Date:  2011-05-18       Impact factor: 3.984

4.  Imaging the clear cell renal cell carcinoma proteome.

Authors:  Todd M Morgan; Erin H Seeley; Oluwole Fadare; Richard M Caprioli; Peter E Clark
Journal:  J Urol       Date:  2012-09-23       Impact factor: 7.450

5.  Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations.

Authors:  Niroshini J Nirmalan; Christopher Hughes; Jianhe Peng; Therese McKenna; James Langridge; David A Cairns; Patricia Harnden; Peter J Selby; Rosamonde E Banks
Journal:  J Proteome Res       Date:  2010-12-23       Impact factor: 4.466

6.  Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.

Authors:  Heike Junker; Simone Venz; Uwe Zimmermann; Andrea Thiele; Christian Scharf; Reinhard Walther
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

7.  A proteomic view at T cell costimulation.

Authors:  Rudolf Lichtenfels; Gunter Rappl; Andreas A Hombach; Christian V Recktenwald; Sven P Dressler; Hinrich Abken; Barbara Seliger
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

8.  Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer.

Authors:  Anne-Marie Ray; Nilshad Salim; Mckayla Stevens; Siddhi Chitre; Sanofar Abdeen; Alex Washburn; Jared Sivinski; Heather M O'Hagan; Eli Chapman; Steven M Johnson
Journal:  Bioorg Med Chem       Date:  2021-04-19       Impact factor: 3.461

9.  Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.

Authors:  Sandra Leisz; Kristin Schulz; Susanne Erb; Peter Oefner; Katja Dettmer; Dimitrios Mougiakakos; Ena Wang; Francesco M Marincola; Franziska Stehle; Barbara Seliger
Journal:  Oncotarget       Date:  2015-05-10

10.  iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.

Authors:  John W Crabb; Bo Hu; John S Crabb; Pierre Triozzi; Yogen Saunthararajah; Raymond Tubbs; Arun D Singh
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.